Search

Displaying results 7221 - 7230 of 10000 in total
  1. Drug

    Envonalkib

    go.drugbank.com/drugs/DB21585
    Experimental

    The usage of the INN stem '-alkib' in the name indicates that Envonalkib is a ALK (anaplastic lymphoma kinase) inhibitor. Envonalkib has a monoisotopic molecular weight of 505.14 Da.

  2. Drug

    Zurletrectinib

    go.drugbank.com/drugs/DB21601
    Experimental

    The usage of the INN stem '-trectinib' in the name indicates that Zurletrectinib is a tropomyosin receptor kinase (TRK) inhibitor. Zurletrectinib has a monoisotopic molecular weight of 415.16 Da.

  3. Drug

    Rolusafine

    go.drugbank.com/drugs/DB21617
    Experimental

    The usage of the INN stem '-afine' in the name indicates that Rolusafine is a antifungal squalene mono-oxygenase inhibitor. Rolusafine has a monoisotopic molecular weight of 306.14 Da.

  4. Drug

    Merigolix

    go.drugbank.com/drugs/DB21628
    Experimental

    The usage of the INN stem '-golix' in the name indicates that Merigolix is a gonadotropin releasing hormone (GnRH) antagonist. Merigolix has a monoisotopic molecular weight of 752.24 Da.

  5. Drug

    Lerzeparib

    go.drugbank.com/drugs/DB21650
    Experimental

    The usage of the INN stem '-parib' in the name indicates that Lerzeparib is a poly-ADP-Ribose polymerase inhibitor. Lerzeparib has a monoisotopic molecular weight of 365.15 Da.

  6. Drug

    Nurandociguat

    go.drugbank.com/drugs/DB21720
    Investigational

    The usage of the INN stem '-ciguat' in the name indicates that Nurandociguat is a guanylate cyclase activator and stimulator. Nurandociguat has a monoisotopic molecular weight of 571.25 Da.

  7. Drug

    BZL101

    go.drugbank.com/drugs/DB05051
    Investigational

    BZL101 is an oral drug designed for the treatment of advanced breast cancer with a novel mechanism of action. BZL101 targets diseased cells while leaving normal cells healthy and intact.

  8. Drug

    TOL2

    go.drugbank.com/drugs/DB17918
    Experimental

    TOL2 is a modified form of the acetylcholine receptor being investigated for the treatment of myasthenia gravis.[A260117]

  9. Drug

    GSK2245035

    go.drugbank.com/drugs/DB16076
    Investigational

    GSK2245035 is under investigation in clinical trial NCT02833974 (Effect of the GSK2245035 on the Allergen-induced Asthmatic Response).

  10. Drug

    β-Methylfentanyl

    go.drugbank.com/drugs/DB09171
    ExperimentalIllicit

    β-Methylfentanyl is an analgesic of the _opioid_ class. It is an analog of the potent opioid, fentanyl.